Posts

Showing posts from June, 2023

Fagron TrichoTest™

  Fagron TrichoTest™ Priscila Arbex, Director of Clinical Affairs GX Sciences – a Fagron company   Introduction Hair is not merely a physical attribute; it is an integral part of our identity, shaping our self-perception and influencing our psychological well-being. The intricate cycle of hair growth, consisting of growth (anagen), involution (catagen), and rest (telogen), is a delicate balance. Most people lose between 50 to 100 hairs each day due to this natural process. Alopecia, an abnormal condition characterized by hair loss, disrupts this finely tuned balance. This condition, which can affect any part of the body but most commonly targets the scalp, results from various factors, including age, autoimmune conditions, or stress. The primary types of scalp alopecia include androgenetic alopecia, alopecia areata, and a thinning of hair known as telogen effluvium. Alopecia treatment encompasses a wide range of treat­ment options and no inclusive genetic test for predict­i